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Abstract 
Objective: objective of our study is to investigate and establish the frequency of raised red cell distribution 
width in acute exacerbation of COPD patients. 
Study design: Cross sectional study 
Place and Duration of study: This study was conducted in pulmonology department of Nishtar Hospital Multan 
from January 2016 to December 2017. 
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Methods: Total 384 patients were selected by non-probability consecutive sampling and approval of study was 
taken from ethical committee of the institution. Written permission of study was signed by every patient enrolled 
in study. Numerical variables like age, weight, white blood cells, platelets, MCV, hemoglobin (Hb) and duration 
of COPD were analyzed statically by taking their mean and standard deviation and t-test was applied to test their 
significance. Non numerical variables like gender, anemia, thrombocytopenia, income and area of living were 
statistically analyzed by taking their frequency and chi square test was applied to test their significance. While 
the outcome variable red cell distribution width was assessed by 3-part hematology chamber.  
Results: Overall, there were 100% (n=384) patients were included, in this study, both genders. There were 
60.7% (n=233) males and 39.3% (n=151) females. 72.1% (n=277) patients belonged to urban areas while 27.9% 
(n=107) belonged to rural areas. 69% (n=265) had good income and 31% (n=119) had low income. The mean 
age and BMI of the patients was 65.22±6.45 years and 26.21±2.18 kg/m2 respectively. There were 26% (n=100) 
patients between 40-60 years while majority of the patients i.e. 74% (n=284) between 61-80 years of age. The 
distribution of BMI of the patients observed as; 39.3% (n=151) patients between 18-25 kg/m2 and 60.7% 
(n=233) patients between 26-32 kg/m2. The main outcome variable of this study was red cell distribution width. 
The Mean±S.D of red cell distribution width was 14.03±1.62%. While, red cell distribution width noted as 
normal and raised; 54.9% (n=211) and 45.1% (n=173) respectively. 
Conclusion: Study concluded that there was significant prevalence of raised red cell distribution width (RDW) 
in acute exacerbation of COPD patients. This easy, inexpensive and quick parameter should be investigated 
further. So it can be used as prognostic marker and predictor of mortality in acute exacerbation of COPD 
patients. 
Key words: Acute exacerbation of COPD (AECOPD), red cell distribution width (RDW), COPD, Inflammation. 
 
Introduction 
          Chronic obstructive pulmonary disease (COPD)is irreversible chronic air flow limitation and inflammatory 
obstructive disease of lung {1}. It is third most common cause of death {2} after ischemic heart disease and 
stroke in whole world in 2010. Most cases of COPD are caused by smoking {3}. Other contributing factors for 
many individuals, who developed COPD are environmental pollution, bio-fuel exposure and chemicals found in 
many work environments {4-5}. Not every smoker develops COPD {6} but most COPD cases (about 90% of 
them) have smoked. In the course of disease acute exacerbations of COPD are most significant events and its 
mortality in hospital is recorded as 5.8%, 7.25%, 7.4% and 10% {7-10}. Acute exacerbation of COPD 
(AECOPD) are responsible for approximately 50-70% of the cost associated with COPD. Many biomarkers are 
used for predicting their association with AECOPD and they are also used for predicting the outcome in 
AECOPD patients after hospitalization. It helps the clinicians in better management and making good decisions. 
        The red cell distribution width (RDW) represents the variability in the size of erythrocytes in blood 
circulation {11}. Red cell distribution width (RDW) is mainly used in differential diagnosis of microcytic 
anemia {12}. It has been reported that increased values of red cell distribution width are related with chronic 
inflammation which changes erythropoiesis and red cell membrane. It is reported that red cell distribution width 
is good predictor of mortality in older adults and general population {13}. Red cell distribution width has been 
defined as prognostic factor {14} in many clinical situations like congestive heart failure, coronary heart disease 
and pulmonary hypertension. Mortality rates increased 5 fold from the lowest to the highest quartile of RDW. 
Many diseases in pulmonology like pulmonary embolism, lung cancer, community acquired pneumonia, stable 
COPD and AECOPD have shown relationship of mortality with higher red cell distribution width values. Few 
studies have described red cell distribution width as predictor of mortality in many conditions. We want to 
investigate the frequency of raised red cell distribution width in AECOPD patients so that it can help to 
determine the outcome in AECOPD patients. Our study will provide a ground to establish the prevalence of 
raised red cell distribution width in acute exacerbation of COPD patients in our geographical area of South 
Punjab. It will provide bases to further investigate the issue in this area. Study done by Shaghayegh Rahimyar et 
al. was taken as reference study {19}. 
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Material and methods 
     We conducted cross sectional study at Nishtar Hospital Multan from January 2016 to December 2017. Total 
128 patients, who were known cases of COPD, diagnosed as AECOPD clinically by chest consultants, having at 
least five years of experience of working as consultant in pulmonology, at the time of admission were enrolled 
by non-probability consecutive sampling. Approval of study was obtained from ethical committee of the 
institution. Performa for the permission of study was signed by each patient. Exclusion criteria were the 
following:1) patients having history of autoimmune disorders 2) sever immune depression (HIV infection or 
sever hematological diseases) 3) patients who were taking any medications for systemic diseases like diabetes 
and hypertension. For our study sample size was calculated using reference from a previous study by 
Shaghayegh Rahimyar et al. For which confidence interval was taken as 95 %, power of study 80, 48.2% of all 
acute exacerbation of COPD patients have elevated red cell distribution width (www.openepi.com). 
All patients of acute exacerbation of COPD were enrolled by diagnosing and admitting them in ward from 
emergency department and outdoor department. A detailed history of symptoms, duration of COPD, smoking 
status, previous drug history, professional history and history of allergy was taken. It was asked about any 
history of systemic diseases like diabetes, hypertension and cardiovascular diseases. Through clinical 
examination was conducted in each patient to check the severity of disease, its complication and presence of any 
other systemic disease. Personal information like age gender, area of living, income status and BMI was taken by 
filling the Performa. 
    Whole blood count including red cell distribution width, MCV, hemoglobin, platelets, WBC were measured 
from venous blood samples taken at the time of admission in ward within 6 hours. FEV1/FVC were taken on 
first day. Best of three values were taken.  
RDW is measured in 3-part hematology cell counter. RDW normal range was between 11.3% to 13.9% in our 
laboratory. Red cell distribution width >13.9% was considered as raised level.  
Data was analyzed by using software SPSS vol.23.Numerical variables like age, BMI, platelets, white blood 
cells, MCV, hemoglobin and duration of COPD were statistically analyzed by using their mean and standard 
deviation. Non numerical variables like gender, thrombocytopenia, anemia and area of living were statistically 
analyzed by using their frequency. Chi-square and t-test were applied to check the significance of these variables 
accordingly. P value <0.05 was taken as significant. 
 
Results: 
 Overall, there were 100% (n=384) patients were included, in this study, both genders. There were 
60.7% (n=233) males and 39.3% (n=151) females. 72.1% (n=277) patients belonged to urban areas while 27.9% 
(n=107) belonged to rural areas. 69% (n=265) had good income and 31% (n=119) had low income. The mean 
age and BMI of the patients was 65.22±6.45 years and 26.21±2.18 kg/m2 respectively. There were 26% (n=100) 
patients between 40-60 years while majority of the patients i.e. 74% (n=284) between 61-80 years of age. The 
distribution of BMI of the patients observed as; 39.3% (n=151) patients between 18-25 kg/m2 and 60.7% 
(n=233) patients between 26-32 kg/m2. (Table. 1). 
The main outcome variable of this study was red cell distribution width. The Mean±S.D of RDW was 
14.03±1.62%. While, red cell distribution width noted as normal and raised; 54.9% (n=211) and 45.1% (n=173) 
respectively (Table. 3). Anemia was noted as 37% (n=142) patients and thrombocytopenia noted as 39.8% 
(n=153). The Mean±S.D MCV, WBC, platelets, Hb and duration of COPD of the patients was 89.82±4.57fL, 
9355.84±465.68, 150319.1±831.83, 13.17±3.76g/dl and 57.81±1.88 months respectively. (Table. 2). 
No association was found between red cell distribution width and gender (p=0.140), area of living 
(p=0.076), Smoking status (p=0.125), stratified age (p=0.344), stratified BMI (p=0.060), anemia (p=0.392), 
Thrombocytopenia (p=0.664), MCV (p=0.073), WBC (p=0.639), Platelets (p=0.266), Hb (p=0.629), duration of 
COPD (p=0.402) except income (p=0.033), after applying chi-square and independent samples t test. (Table. 1-
2). 
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Table. 1 
Demographic Variables 
 
 
 
 
  
 
 
 
Characteristics Frequency Percentage (%) Test of Sig. 
Gender  
Male 233 60.7 χ2 =2.178 
p=0.140 Female 151 39.3 
Total  384 100.0 
Area 
Rural 107 27.9 χ2 =0.076 
p=0.783 Urban 277 72.1 
Total 384 100.0 
Income 
Low 119 31.0 χ2 =4.54 
p=0.033 Good 265 69.0 
Total 384 100.0 
Smoking Status 
Smoker 119 31.0 χ2 =4.15 
p=0.125 Non-Smoker 50 13.0 
Ex-Smoker 215 56.0 
Total 384 100.0 
Stratified Age 
40-60 Years 100 26.0 χ2 =0.897 
p=0.344 61-80 Years 284 74.0 
Total 384 100.0 
Stratified BMI 
18-25  kg/m2 151 39.3 χ2 =3.54 
p=0.060 26-32 kg/m2 233 60.7 
Total 384 100.0 
Descriptive Statistics 
Age 65.22±6.45 years 
BMI 26.21±2.18 kg/m2 
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Table. 2 
Hematological and variables having impact on COPD severity. 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
Table. 3 
RDW 
 
 
 
 
 
Discussion 
Red cell distribution width (RDW) had been studied and found associated with many clinical conditions. 
Importance of knowing the association is that it can be used as prognostic marker in diseases and also predictor 
of clinical outcomes, such as mortality and morbidity, in these conditions. 
The main finding of study was that raised red cell distribution width was significantly prevalent in acute 
exacerbation of COPD patients. Study found that 45.1% of all acute exacerbation of COPD patients had higher 
than normal red cell distribution width values. These results were closely resembling to another study done by 
Shaghayegh Rahimirad et al. {19}. 
In previous study red cell distribution width had been found associated with ischemic strokes in younger adults 
age less than 55 years {15}. In JUPITER trial among others red cell distribution width was one important 
component in predicting mortality {16}. In study done by Syed Atif Safder et al. red cell distribution width was 
found independent predictor of mortality in critical ill patients in ICU {17}. Red cell distribution width as 
Characteristics Frequency Percentage (%) Test of Sig. 
Anemia 
Yes 142 37.0 χ2 =0.73 
p=0.392 No 242 63.0 
Total 384 100.0 
Thrombocytopenia 
Yes 153 39.8 χ2 =0.188 
p=0.664 No 231 60.2 
Total 384 100.0 
Descriptive Statistics ( Mean±S.D) 
MCV 89.82±4.57fL t=1.79 
p=0.073 
WBC 9355.84±465.68 t=0.473 
p=0.637 
Platelets 150319.1±831.83 t=1.114 
p=0.266 
Hb 13.17±3.76 g/dl t=0.483 
p=0.629 
Duration of COPD 57.81±1.88 months t=-0.839 
p=0.402 
Characteristics Frequency Percentage (%) 
Normal 211 54.9 
Raised 173 45.1 
Total  384 100.0 
Mean±S.D 14.03±1.62% 
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prognostic factor had been investigated and found that it is prognostic factor in sepsis and septic shock patients 
{18}. 
So by establishing significant prevalence of elevated red cell distribution width. It can be investigated that red 
cell distribution width is predictor of mortality and can be compared with other markers of prediction. Red cell 
distribution width reported as superior marker of predicting mortality as compared to N-terminal-pro-B-type 
natriuretic peptide in pulmonary hypertension {20}. Red cell distribution width was reported in cohort study a 
significant predictor of mortality {21}. 
Study of 109,675 patients on dialysis, higher mortality found in patients with high red cell distribution width 
{22}. 
Dharmeshkumar Patel et al. investigated association of red cell distribution width and severity of disease {23}. 
In stable COPD it had been reported as predictor of mortality {24}. 
Exact mechanism of significant prevalence of raised red cell distribution width in acute exacerbation of COPD 
patients is unclear. It might be due to chronic inflammation that causes anisocytosis and interferes with 
erythropoiesis. A positive correlation found between red cell distribution width and other inflammatory markers 
such as CRP, ESR and inflammatory cytokines done on systemic lupus erythematous patients, rheumatoid 
arthritis patients. It had been established that COPD is associated with oxidative stress {25}. 
Independent to the iron status, red cell distribution width level increased in anemia of chronic diseases. It had 
been reported that inflammation causes red blood cells membrane deformability, promotes death of RBCs and 
alters erythropoiesis. COPD is also chronic inflammatory disease. So it can be thought that RDW is reflection of 
inflammation in AECOPD. Another rationale of raised RDW in COPD patients can be the malnutrition in these 
patients. Malnutrition is comorbidity in COPD and it is directly associated with the disease {26}. It leads to 
impaired erythrocytes formation, which result in heterogeneous RBCs and increased red cell distribution width. 
There are two advantages of considering RDW as prognostic marker. First, it is quick, easy and inexpensive test 
and can be tested even in community. Second, as compared to ESR, CRP and platelets, life span of RBC is 
approximately 120 days. So it may reflect long duration of patient’s condition. 
As study had found a significant prevalence of raised red cell distribution width in acute exacerbation of COPD 
patients so it should be researched further. So that it could be considered as prognostic inflammatory marker in 
AECOPD. 
Major limitation of study was its cross sectional design. Second the sample size of study was relatively small. 
Finally, it did not measure and compare other inflammatory markers association in AECOPD. 
 
Conclusion 
Study concluded that there was significant prevalence of raised red cell distribution width (RDW) in acute 
exacerbation of COPD patients. This easy, inexpensive and quick parameter should be investigated further. So it 
can be used as prognostic marker and predictor of mortality in acute exacerbation of COPD patients. 
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